新晨科技(300542.SZ)完成受讓清林軟件部分股權
格隆匯 6 月 15日丨新晨科技(300542.SZ)公佈,公司於2020年6月8日召開了第九屆董事會第二十五次會議,審議通過了《關於新晨科技股份有限公司受讓北京清林軟件科技有限公司部分股權的議案》,同意公司擬通過現金方式受讓範少峯、歐陽芬安各自持有的北京清林軟件科技有限公司(“清林軟件”)15%股權。此次股權轉讓後,新晨科技將持有清林軟件55%股權,清林軟件將成為公司的控股子公司。
近日,清林軟件已辦理完成相關股權轉讓的工商變更登記,並取得了由北京市海淀區市場監督管理局換髮的《營業執照》。截至公告披露日,此次公司受讓清林軟件部分股權事項已實施完畢。清林軟件成為公司的控股子公司,納入合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.